Advertisement

Topics

Pro-Trader Daily: Corporate News Blog - FDA Grants Orphan Drug Designation to Omeros' OMS721 for Treatment of IgA Nephropathy

07:20 EDT 8 Aug 2017 | FinanzNachrichten

Research Desk Line-up: Intercept Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 8, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines ...

Original Article: Pro-Trader Daily: Corporate News Blog - FDA Grants Orphan Drug Designation to Omeros' OMS721 for Treatment of IgA Nephropathy

NEXT ARTICLE

More From BioPortfolio on "Pro-Trader Daily: Corporate News Blog - FDA Grants Orphan Drug Designation to Omeros' OMS721 for Treatment of IgA Nephropathy"

Quick Search
Advertisement